Cargando…
Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
The germline TP53 p.R337H mutation is reported as the most common germline TP53 variant. It exists at a remarkably high frequency in the population of southeast Brazil as founder mutation in two distinct haplotypes with the most frequent co-segregating with the p.E134∗ variant of the XAF1 tumor supp...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597792/ https://www.ncbi.nlm.nih.gov/pubmed/37794678 http://dx.doi.org/10.1016/j.xhgg.2023.100244 |
_version_ | 1785125421674659840 |
---|---|
author | Pinto, Emilia M. Fridman, Cintia Figueiredo, Bonald C. Salvador, Hector Teixeira, Manuel R. Pinto, Carla Pinheiro, Manuela Kratz, Christian P. Lavarino, Cinzia Legal, Edith A.M. F. Le, Anh Kelly, Gregory Koeppe, Erika Stoffel, Elena M. Breen, Kelsey Hahner, Stefanie Heinze, Britta Techavichit, Piti Krause, Amanda Ogata, Tsutomu Fujisawa, Yasuko Walsh, Michael F. Rana, Huma Q. Maxwell, Kara N. Garber, Judy E. Rodriguez-Galindo, Carlos Ribeiro, Raul C. Zambetti, Gerard P. |
author_facet | Pinto, Emilia M. Fridman, Cintia Figueiredo, Bonald C. Salvador, Hector Teixeira, Manuel R. Pinto, Carla Pinheiro, Manuela Kratz, Christian P. Lavarino, Cinzia Legal, Edith A.M. F. Le, Anh Kelly, Gregory Koeppe, Erika Stoffel, Elena M. Breen, Kelsey Hahner, Stefanie Heinze, Britta Techavichit, Piti Krause, Amanda Ogata, Tsutomu Fujisawa, Yasuko Walsh, Michael F. Rana, Huma Q. Maxwell, Kara N. Garber, Judy E. Rodriguez-Galindo, Carlos Ribeiro, Raul C. Zambetti, Gerard P. |
author_sort | Pinto, Emilia M. |
collection | PubMed |
description | The germline TP53 p.R337H mutation is reported as the most common germline TP53 variant. It exists at a remarkably high frequency in the population of southeast Brazil as founder mutation in two distinct haplotypes with the most frequent co-segregating with the p.E134∗ variant of the XAF1 tumor suppressor and an increased cancer risk. Founder mutations demonstrate linkage disequilibrium with neighboring genetic polymorphic markers that can be used to identify the founder variant in different geographic regions and diverse populations. We report here a shared haplotype among Brazilian, Portuguese, and Spanish families and the existence of three additional distinct TP53 p.R337H alleles. Mitochondrial DNA sequencing and Y-STR profiling of Brazilian carriers of the founder TP53 p.R337H allele reveal an excess of Native American haplogroups in maternal lineages and exclusively European haplogroups in paternal lineages, consistent with communities established through male European settlers with extensive intermarriage with Indigenous women. The identification of founder and independent TP53 p.R337H alleles underlines the importance for considering the haplotype as a functional unit and the additive effects of constitutive polymorphisms and associated variants in modifier genes that can influence the cancer phenotype. |
format | Online Article Text |
id | pubmed-10597792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105977922023-10-26 Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility Pinto, Emilia M. Fridman, Cintia Figueiredo, Bonald C. Salvador, Hector Teixeira, Manuel R. Pinto, Carla Pinheiro, Manuela Kratz, Christian P. Lavarino, Cinzia Legal, Edith A.M. F. Le, Anh Kelly, Gregory Koeppe, Erika Stoffel, Elena M. Breen, Kelsey Hahner, Stefanie Heinze, Britta Techavichit, Piti Krause, Amanda Ogata, Tsutomu Fujisawa, Yasuko Walsh, Michael F. Rana, Huma Q. Maxwell, Kara N. Garber, Judy E. Rodriguez-Galindo, Carlos Ribeiro, Raul C. Zambetti, Gerard P. HGG Adv Article The germline TP53 p.R337H mutation is reported as the most common germline TP53 variant. It exists at a remarkably high frequency in the population of southeast Brazil as founder mutation in two distinct haplotypes with the most frequent co-segregating with the p.E134∗ variant of the XAF1 tumor suppressor and an increased cancer risk. Founder mutations demonstrate linkage disequilibrium with neighboring genetic polymorphic markers that can be used to identify the founder variant in different geographic regions and diverse populations. We report here a shared haplotype among Brazilian, Portuguese, and Spanish families and the existence of three additional distinct TP53 p.R337H alleles. Mitochondrial DNA sequencing and Y-STR profiling of Brazilian carriers of the founder TP53 p.R337H allele reveal an excess of Native American haplogroups in maternal lineages and exclusively European haplogroups in paternal lineages, consistent with communities established through male European settlers with extensive intermarriage with Indigenous women. The identification of founder and independent TP53 p.R337H alleles underlines the importance for considering the haplotype as a functional unit and the additive effects of constitutive polymorphisms and associated variants in modifier genes that can influence the cancer phenotype. Elsevier 2023-10-04 /pmc/articles/PMC10597792/ /pubmed/37794678 http://dx.doi.org/10.1016/j.xhgg.2023.100244 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pinto, Emilia M. Fridman, Cintia Figueiredo, Bonald C. Salvador, Hector Teixeira, Manuel R. Pinto, Carla Pinheiro, Manuela Kratz, Christian P. Lavarino, Cinzia Legal, Edith A.M. F. Le, Anh Kelly, Gregory Koeppe, Erika Stoffel, Elena M. Breen, Kelsey Hahner, Stefanie Heinze, Britta Techavichit, Piti Krause, Amanda Ogata, Tsutomu Fujisawa, Yasuko Walsh, Michael F. Rana, Huma Q. Maxwell, Kara N. Garber, Judy E. Rodriguez-Galindo, Carlos Ribeiro, Raul C. Zambetti, Gerard P. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility |
title | Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility |
title_full | Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility |
title_fullStr | Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility |
title_full_unstemmed | Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility |
title_short | Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility |
title_sort | multiple tp53 p.r337h haplotypes and implications for tumor susceptibility |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597792/ https://www.ncbi.nlm.nih.gov/pubmed/37794678 http://dx.doi.org/10.1016/j.xhgg.2023.100244 |
work_keys_str_mv | AT pintoemiliam multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT fridmancintia multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT figueiredobonaldc multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT salvadorhector multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT teixeiramanuelr multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT pintocarla multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT pinheiromanuela multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT kratzchristianp multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT lavarinocinzia multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT legaledithamf multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT leanh multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT kellygregory multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT koeppeerika multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT stoffelelenam multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT breenkelsey multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT hahnerstefanie multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT heinzebritta multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT techavichitpiti multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT krauseamanda multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT ogatatsutomu multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT fujisawayasuko multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT walshmichaelf multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT ranahumaq multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT maxwellkaran multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT garberjudye multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT rodriguezgalindocarlos multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT ribeiroraulc multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility AT zambettigerardp multipletp53pr337hhaplotypesandimplicationsfortumorsusceptibility |